ESRRA and prostate carcinoma: Since ERRα can cross-talk to AR signaling by its direct transactivation of common ARE-containing AR targets [32], it could be likely that the transactivation of T:E fusion gene by ERRα could be indirectly mediated through its interference on AR signaling in prostate cancer cells.